BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lou Y, Wang Q, Zheng J, Hu H, Liu L, Hong D, Zeng S. Possible Pathways of Capecitabine-Induced Hand–Foot Syndrome. Chem Res Toxicol 2016;29:1591-601. [DOI: 10.1021/acs.chemrestox.6b00215] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Peccerillo F, Pampena R, Giannetti L, Pellacani G, Longo C. Capecitabine-induced eruptive acral hyperpigmentation: Clinical and dermoscopic evaluation of two cases. Dermatol Ther 2019;32:e12853. [PMID: 30748073 DOI: 10.1111/dth.12853] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Komatsu H, Yagasaki K, Hamamoto Y, Takebayashi T. Falls and Physical Inactivity in Patients with Gastrointestinal Cancer and Hand-Foot Syndrome. Asia Pac J Oncol Nurs 2018;5:307-13. [PMID: 29963593 DOI: 10.4103/apjon.apjon_8_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Ab Mutalib NS, Md Yusof NF, Abdul SN, Jamal R. Pharmacogenomics DNA Biomarkers in Colorectal Cancer: Current Update. Front Pharmacol 2017;8:736. [PMID: 29075194 DOI: 10.3389/fphar.2017.00736] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
4 Deng B, Sun W. Herbal medicine for hand-foot syndrome induced by fluoropyrimidines: A systematic review and meta-analysis. Phytother Res 2018;32:1211-28. [PMID: 29682836 DOI: 10.1002/ptr.6068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yu R, Wu X, Jia L, Lou Y. Effect of Chinese Herbal Compound LC09 on Patients With Capecitabine-Associated Hand-Foot Syndrome: A Randomized, Double-Blind, and Parallel-Controlled Trial. Integr Cancer Ther 2020;19:1534735420928466. [PMID: 32597691 DOI: 10.1177/1534735420928466] [Reference Citation Analysis]
6 Alam W, Bouferraa Y, Haibe Y, Mukherji D, Shamseddine A. Management of colorectal cancer in the era of COVID-19: Challenges and suggestions. Sci Prog 2021;104:368504211010626. [PMID: 33878982 DOI: 10.1177/00368504211010626] [Reference Citation Analysis]
7 Hiromoto S, Kawashiri T, Yamanaka N, Kobayashi D, Mine K, Inoue M, Uchida M, Shimazoe T. Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome. Sci Rep 2021;11:8964. [PMID: 33903667 DOI: 10.1038/s41598-021-88460-9] [Reference Citation Analysis]
8 Karimi E, Gharib B, Rostami N, Navidpour L, Afshar M. Clinical efficacy of a topical polyherbal formulation in the management of fluorouracil -associated hand-foot syndrome. Journal of Herbal Medicine 2019;17-18:100270. [DOI: 10.1016/j.hermed.2019.100270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Shiraishi T, Nishizawa Y, Nakajima M, Kado R, Ikeda K, Tsukada Y, Sasaki T, Ito M. Risk factors for the incidence and severity of peristomal skin disorders defined using two scoring systems. Surg Today 2020;50:284-91. [DOI: 10.1007/s00595-019-01876-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li M, Chen J, Liu S, Sun X, Xu H, Gao Q, Chen X, Xi C, Huang D, Deng Y, Zhang F, Gao S, Qiu S, Tao X, Zhai J, Wei H, Yao H, Chen W. Spermine-Related DNA Hypermethylation and Elevated Expression of Genes for Collagen Formation are Susceptible Factors for Chemotherapy-Induced Hand-Foot Syndrome in Chinese Colorectal Cancer Patients. Front Pharmacol 2021;12:746910. [PMID: 34539419 DOI: 10.3389/fphar.2021.746910] [Reference Citation Analysis]
11 Gao Y, Liu Z, Liu Y. Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects. World J Surg Oncol 2021;19:280. [PMID: 34535176 DOI: 10.1186/s12957-021-02393-1] [Reference Citation Analysis]
12 Kwakman JJM, Elshot YS, Punt CJA, Koopman M. Management of cytotoxic chemotherapy-induced hand-foot syndrome. Oncol Rev 2020;14:442. [PMID: 32431787 DOI: 10.4081/oncol.2020.442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Yang S, Tseng S, Wang C, Young T, Chen K, Shieh M. Magnetic nanomedicine for CD133-expressing cancer therapy using locoregional hyperthermia combined with chemotherapy. Nanomedicine 2020;15:2543-61. [DOI: 10.2217/nnm-2020-0222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Watanabe A, Yang CC, Cheung WY. Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients. Med Oncol 2018;35:125. [PMID: 30117039 DOI: 10.1007/s12032-018-1188-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Li M, Sun X, Yao H, Chen W, Zhang F, Gao S, Zou X, Chen J, Qiu S, Wei H, Hu Z, Chen W. Genomic methylation variations predict the susceptibility of six chemotherapy related adverse effects and cancer development for Chinese colorectal cancer patients. Toxicol Appl Pharmacol 2021;427:115657. [PMID: 34332992 DOI: 10.1016/j.taap.2021.115657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chen J, Wang Z. How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs. J Oncol Pharm Pract 2021;27:919-29. [PMID: 33874817 DOI: 10.1177/10781552211009291] [Reference Citation Analysis]
17 Cohen PR. Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine. Cureus 2017;9:e969. [PMID: 28191373 DOI: 10.7759/cureus.969] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Nakamura N, Shiraiwa H, Haruna Y, Ichijima T, Takeda T, Hasegawa K, Kusumoto M, Yano Y. Effectiveness of protocol-based pharmacotherapy management collaboration between hospital and community pharmacists to address capecitabine-related hand-foot syndrome in cancer patients: a retrospective study. J Pharm Health Care Sci 2021;7:8. [PMID: 33641672 DOI: 10.1186/s40780-021-00191-1] [Reference Citation Analysis]
19 Lou Y, Wang Q, Zheng J, Wang X, Jiang W, Zheng Y, Zhao Q, Qiu Y, Zeng S. Identification of the Novel Capecitabine Metabolites in Capecitabine-Treated Patients with Hand-Foot Syndrome. Chem Res Toxicol 2018;31:1069-79. [PMID: 30230321 DOI: 10.1021/acs.chemrestox.8b00150] [Reference Citation Analysis]
20 van Beek MWH, Roukens M, Jacobs WCH, Timmer-Bonte JNH, Kramers C. Real-World Adverse Effects of Capecitabine Toxicity in an Elderly Population. Drugs Real World Outcomes 2018;5:161-7. [PMID: 29934933 DOI: 10.1007/s40801-018-0138-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Liu R, Jiang Y, Hu X, Wu J, Jiang W, Jin G, Luan Y. A preclinical evaluation of cytarabine prodrug nanofibers assembled from cytarabine-lauric acid conjugate toward solid tumors. Int J Pharm 2018;552:111-8. [PMID: 30268848 DOI: 10.1016/j.ijpharm.2018.09.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]